6 completed, 2 unknown. 8 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 8 | Completed 6, Unknown 2 |
Follow Vulvovaginal Atrophy: new trials by email Literature Review of Vulvovaginal Atrophy trials Research Report on Vulvovaginal Atrophy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Study to Evaluate the Efficacy of Prasterone Treatment for Atrophy Vulvovaginal in Postmenopausal Women With Vulvar / Vestibular Pain Prasterone 6.5 MG, Placebo - Vulvovaginal Atrophy | Phase 3 | Unknown | Dr. Santiago Palacios | 50 | 2020-12-22 | 2021-06-02 |
| Evaluation of the Acceptability and Efficacy of 10 Micrograms of Estradiol Vaginal Tablets vs Promestriene Vaginal Cream Estradiol 10 MCG Vaginal Tablet [VAGIFEM], Promestriene Vaginal - Vulvovaginal Atrophy | Phase 3 | Completed | Instituto Palacios | 120 | 2020-01-09 | 2021-02-11 |
| Examining Effects of Intrarosa in Women With Genitourinary Syndrome of Menopause/Vulvovaginal Atrophy Intrarosa, Placebos - Menopause, Genitourinary Syndrome of Menopause | Phase 3 | Unknown | Center for Vulvovaginal Disorders | 40 | 2019-03-02 | 2019-01-31 |
| Evaluation of Fractional CO2 Laser Treatment Efficacy and Comparison to Vaginal Estrogen Therapy in Postmenopausal Women With Vulvovaginal Atrophy CO2 laser, Estrogen, Placebo of Estrogen - Vulvovaginal Atrophy | Phase 3 | Completed | Faculdade de Medicina do ABC | 45 | 2015-03-01 | 2016-06-28 |
| Estradiol Vaginal Softgel Capsules in Treating Symptoms of Vulvar and Vaginal Atrophy in Postmenopausal Women Estradiol, Placebo - Vulvovaginal Atrophy, Menopause | Phase 3 | Completed | TherapeuticsMD | 764 | 2014-09-01 | 2017-05-25 |
| Study to Evaluate Safety and Efficacy of WC3011 (Estradiol Vaginal Cream) in Postmenopausal Women With Dyspareunia WC3011 Estradiol Vaginal Cream, Vehicle - Vulvovaginal Atrophy | Phase 3 | Completed | Warner Chilcott | 550 | 2013-04-12 | 2022-05-09 |
| Multicenter Study to Evaluate Safety and Efficacy of WC3011 (Estradiol Vaginal Cream) in Postmenopausal Women Vehicle, WC3011 Estradiol Vaginal Cream - Vulvovaginal Atrophy | Phase 3 | Completed | Warner Chilcott | 576 | 2013-01-31 | 2022-05-09 |
| Evaluate Long-Term Safety and Efficacy WC3011 (Estradiol Vaginal Cream) WC3011 Estradiol Vaginal Cream - Vulvovaginal Atrophy | Phase 3 | Completed | Warner Chilcott | 309 | 2011-10-20 | 2022-05-09 |
Dyspareunia (5)
Female Urogenital Diseases (5) · Female Urogenital Diseases and Pregnancy Complications (5) · Genital Diseases (5) · Genital Diseases, Female (5) · Genital Diseases, Male (5) · Male Urogenital Diseases (5) · Mental Disorders (5) · Sexual Dysfunction, Physiological (5) · Sexual Dysfunctions, Psychological (5) · Urogenital Diseases (5)
Dehydroepiandrosterone (2) · Estradiol (2) · Control Groups (1) · Estriol (1) · Estrogens (1) · Lasers, Gas (1) · Vaginal Creams, Foams, and Jellies (1)
Warner Chilcott (3) · Center for Vulvovaginal Disorders (1) · Dr. Santiago Palacios (1) · Faculdade de Medicina do ABC (1) · Instituto Palacios (1) · TherapeuticsMD (1)
United States (5) · Spain (2) · Brazil (1) · Canada (1)
Anna Chan, PharmD (3) · Fernand Labrie, MD (1) · Vera L da Cruz, MD (1)
PMID 15779109, PMID 24605832, PMID 25333211, PMID 28355090, PMID 30238814, PMID 31688572, PMID 34054104, PMID 34813408, PMID 37619252, PMID 40709601